Recall image placeholder

No image published for this recall

Atellica ch enzymatic hemoglobin a1c (a1c e) assay

Official notice

18 Jun 2026

Last checked

18 Jun 2026

Medium riskHealth Canada
Watch Siemens

An official Health Canada notice concerns Atellica ch enzymatic hemoglobin a1c (a1c e) assay. Siemens Healthineers has confirmed, through internal investigation of customer complaints, the potential for intermittent well-to-well bias affecting the A1c_E/A1c_H assay when used on the Atellica CH and Atellica CI systems. This observed bias does not affect every A1c_E reagent lot or reagent pack. However, affected wells cannot currently be identified prospectively, therefore all in-date lots are considered potentially impacted until further notice. Under certain circumstances, this issue may result in:. Falsely depressed patient results when lot calibration is performed using an affected well and patient testing is subsequently performed using an unaffected well.. Falsely elevated patient results when lot calibration is performed using an unaffected well and patient testing is subsequently performed using an affected well. Published 2026-06-18.

What to do now

Contact the manufacturer if you require additional information.

Recall number

82220

Official notice

2026-06-18

The hazard

Siemens Healthineers has confirmed, through internal investigation of customer complaints, the potential for intermittent well-to-well bias affecting the A1c_E/A1c_H assay when used on the Atellica CH and Atellica CI systems. This observed bias does not affect every A1c_E reagent lot or reagent pack. However, affected wells cannot currently be identified prospectively, therefore all in-date lots are considered potentially impacted until further notice. Under certain circumstances, this issue may result in:. Falsely depressed patient results when lot calibration is performed using an affected well and patient testing is subsequently performed using an unaffected well.. Falsely elevated patient results when lot calibration is performed using an unaffected well and patient testing is subsequently performed using an affected well.

How to check if you're affected

Compare the VIN on your vehicle against the official list. If your VIN is listed, follow the official notice.

Lots

calibration

Skus

11097536

Other

RA RA-82220

Model Numbers

11097536

Recall Numbers

82220

Checked manually this time?

The app watches your VIN and alerts you automatically next time — no searching, no checking back.

Turn on automatic VIN checks

Affected products

Product 1

Lot or serial number - All lots., Model or catalogue number - 11097536

Risk / hazard

Siemens Healthineers has confirmed, through internal investigation of customer complaints, the potential for intermittent well-to-well bias affecting the A1c_E/A1c_H assay when used on the Atellica CH and Atellica CI systems. This observed bias does not affect every A1c_E reagent lot or reagent pack. However, affected wells cannot currently be identified prospectively, therefore all in-date lots are considered potentially impacted until further notice. Under certain circumstances, this issue may result in:. Falsely depressed patient results when lot calibration is performed using an affected well and patient testing is subsequently performed using an unaffected well.. Falsely elevated patient results when lot calibration is performed using an unaffected well and patient testing is subsequently performed using an affected well.

Where it was sold

The source does not list specific retailers. See the official notice for where affected vehicles were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Brand

Siemens

Manufacturer

Not provided

Phone

Not provided

Brand: Siemens.

Source & status

Source

Health Canada

Tier

official

Category

HOME

Classification

Type II

App estimate

medium

Recall details

Recall number

82220

Classification

Type II

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
Recall image placeholder

Rapidlab® 348ex system

Medium riskHealth Canada2 Jul 2026
CA
Recall image placeholder

Dimension® creatinine (cre2)

Medium riskHealth Canada2 Apr 2026
CA
Recall image placeholder

Rapidpoint® 500 blood gas systems

Medium riskHealth Canada17 Mar 2026
CA
Recall image placeholder

Wash waste cartridge for rapidpoint® 500 and rapidpoint® 500e

Medium riskHealth Canada16 Jul 2025
CA
Recall image placeholder

Innovance® vwf ac assay

Medium riskHealth Canada4 Jul 2025
CA
Recall image placeholder

Atellica ch diluent

Medium riskHealth Canada26 Feb 2025
CA
Recall image placeholder

Atellica ci system

Medium riskHealth Canada15 Nov 2024
CA
Recall image placeholder

Dimension vista® system - total bilirubin assay

Medium riskHealth Canada21 Aug 2024
CA
Recall image placeholder

Rapidpoint® 500e blood gas system

Medium riskHealth Canada12 Oct 2023
CA
Recall image placeholder

Immulite 2000 sytstem thyroglobulin assay

Medium riskHealth Canada5 Jan 2023
CA
Recall image placeholder

Dimension exl system - cardiac troponin-i (ctni) assay

Medium riskHealth Canada13 Jun 2022
CA
Recall image placeholder

Immulite 2000 system-human chorionic gonadotropin (hcg) assay

Medium riskHealth Canada28 Mar 2022

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 18 Jun 2026. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.